Research study Program year 2024 Source: CMS Open Payments

A Phase I/II, Open-Label, Parallel-Group, Dose Escalation and Expansio

Research payments

$1,579,351

236 payments

Through program year 2024, $1,579,351 in research payments was reported against A Phase I/II, Open-Label, Parallel-Group, Dose Escalation and Expansio, across 236 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

6 rows

Year	Kind	Amount	Payments
2024	Research	$37,114	4
2023	Research	$32,762	16
2022	Research	$16,386	11
2021	Research	$47,234	18
2020	Research	$919,726	119
2019	Research	$526,130	68

Breakdown

Who paid Research payments · program years 2019–2024

GlaxoSmithKline, LLC. $1,579,351 236 payments

Who received the money Research payments · program years 2019–2024

Emory University Organisation paid for research $313,466 24 payments
Indiana University Organisation paid for research $301,067 27 payments
University Of Alabama At Birmingham Organisation paid for research $218,555 24 payments
Washington University Organisation paid for research $122,665 12 payments
Washington University Dept Of Anesthes Organisation paid for research $108,441 13 payments
Chi Institute Organisation paid for research $95,843 16 payments
Ctca Clinical Research INC Organisation paid for research $78,323 4 payments
Biomedical Research Alliance Of New York LLC Organisation paid for research $51,581 31 payments
Michigan State University Organisation paid for research $41,023 6 payments
Mary Crowley Medical Research Center Organisation paid for research $40,482 23 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.